A Call for Gender-Inclusive Global Health Strategies

The WHO\u27s Global Strategy for Women\u27s, Children\u27s, and Adolescents\u27 Health 2016-2030 (GS-WCAH 2016-2030) is a comprehensive plan developed to improve the lives of women, children, and adolescents. Due to the success in the creation, ratification, and advocacy of the GS-WCAH 2016-2030, the clear health outcome disparities between males and females, and the general absence of male health from existing policies and sponsored programs, it is time now to develop a global strategy specifically drafted to improve the lives of men and boys. The following commentary provides three points for why a male-oriented program, like the GS-WCAH 2016-2030, should be created: (a) health outcomes disparities, (b) economic impact of poor male health, and (c) fathers\u27 role in promoting the health of women, children, and adolescents. Implications for how male health can be incorporated into future projects and priorities are provided, as well as advocacy for overall gender-inclusivity in regard to global public health efforts

Desenvolupament d'interfícies d'usuari i visualització d'imatge mèdica en dispositius mòbils Android

Aquest document conté originàriament altre material i/o programari només consultable a la Biblioteca de Ciència i Tecnologia.Aquest treball tracta sobre la realització d'una aplicació per a dispositius Android que permeti visualitzar imatges mèdiques. Amb la col·laboració del parc Taulí de Sabadell s'han realitzat tasques de recerca de requeriments com l'elaboració d'una entrevista o la realització d'una maqueta de paper que s'ha sotmès a una avaluació heurística en un procés iteratiu. Finalment, s'ha implementat una aplicació on es poden visualitzar imatges mèdiques, fer accions sobre elles com canviar el color o fer zoom i accedir a informació del pacient.Este trabajo trata sobre la realización de una aplicación para dispositivos Android que permita visualizar imágenes médicas. Con la colaboración del parc Taulí de Sabadell se han realizado tareas de búsqueda de necesidades como la elaboración de una entrevista o la realización de una maqueta de papel que se ha sometido a una evaluación heurística en un proceso iterativo. Finalmente, se ha implementado una aplicación donde se pueden visualizar imágenes médicas, hacer acciones sobre ellas como cambiar el color o hacer zoom y acceder a información del paciente.This project is about making an Android application for mobile devices that allows viewing medical images. Needfinding tasks were made with the collaboration of parc Taulí de Sabadell, such preparing and doing an interview or making a paper prototype that has been subjected to a heuristic evaluation in an iterative process. Finally, we have implemented an application where you can view medical images, perform actions on them as changing the color or zoom in and access patient information

Towards understanding the behavior of polyelectrolyte surfactant mixtures at the water vapor interface closer to technologically relevant conditions

Polyelectrolyte surfactant mixtures and their interactions with fluid interfaces are an important research field due to their use in technological applications. Most of the existing knowledge on these systems is based on models in which the polyelectrolyte concentration is around 50 times lower than that used in commercial formulations. The present work marks a step to close the gap on the understanding of their behavior under more practically relevant conditions. The adsorption of concentrated mixtures of poly(diallyldimethylammonium) chloride and sodium N lauroyl N methyltaurate at the water-vapor interface with a crude mixing protocol has been studied by different surface tension techniques, Brewster angle microscopy, neutron reflectometry, and several bulk characterization techniques. Kinetically trapped aggregates formed during mixing influence the interfacial morphology of mixtures produced in the equilibrium one phase region, yet fluctuations in the surface tension isotherm result depending on the tensiometric technique applied. At low bulk surfactant concentrations, the free surfactant concentration is very low, and the interfacial composition matches the trend of the bulk complexes, which is a behavior that has not been observed in studies on more dilute mixtures. Nevertheless, a transition to synergistic co-adsorption of complexes and free surfactant is observed at the higher bulk surfactant concentrations studied. This transition appears to be a special feature of these more concentrated mixtures, which deserves attention in future studies of systems with additional components.Comment: Published pape

Water and agriculture

This chapter shows the strong links between water, agriculture and the economy in Latin America and Caribbean (LAC). Both green and blue water are vital for LAC's economies and for its food security. Awareness of LAC's virtual water trade volumes and water footprints alone will not solve the local or global water problems. However, the awareness gained increases the likelihood that optimized water allocation decisions, which consider the hydrological and economical aspects of water resources, are made. • Agriculture is a significant economic sector for many LAC countries with some being major world players in the agricultural commodities world markets, such is the case for Brazil and Argentina who contribute to 13% of the global green water export. At the micro level, agriculture still plays a significant role for the food security of the population. • The consumptive water use of agricultural production was on average 1,057Gm 3 / yr for the period 1996–2005; of which, 95% corresponds to the green water footprint, whereas 5% refers to the blue component. This indicates that LAC relies heavily on green water for agricultural production, i.e. rain-fed agriculture. • Maize is a fundamental crop in Argentina, Brazil, Chile, Mexico and Peru, representing 15% of the total agricultural blue and green water footprint (773,408hm 3 /yr) and contributing to 35% of the agricultural nitrogen pollution, estimated as grey water footprint, in Argentina, Brazil, Chile, Colombia, Mexico and Peru. Only in Mexico, maize contributes 60% of the agricultural grey water footprint. • Grazing represents 24% of the total green water footprint of agriculture in these countries. The blue water consumption by the animal water supply is very significant in Argentina, Brazil, Chile, Mexico and Peru, which amounts to 13% (38,825hm 3 /yr) of the total consumption

Práticas artísticas no ensino básico e secundário

A educação pela arte faz-se através dos seus materiais, da sua operação, da transformação das matérias em ideias novas, em novas coisas. No seu sucesso está implicada uma literacia, uma capacidade interpretativa, ou crítica, sobre a semiosfera cada vez mais povoada, saturada de mensagens parasitárias. A educação implica uma leitura do mundo (Paulo Freire), que se projeta na interpretação de todas as camadas de expressão contemporânea, muitas vezes massificada, por vezes ainda identitária e significativa. Fala-se aqui de valorizar a identidade, exercer a pedagogia da diferença através de uma capacidade problematizadora. No seu contexto, podem exercer-se pedagogias que exploram a visão crítica do artista em interação com a escola, o artista em residência, no movimento A/ R/ Tography. Ou também exercer-se uma pedagogia triangular, centrando a arte, o contexto, a produção e a sua leitura como uma metodologia (Ana Mae Barbosa). O contexto contemporâneo é pós digital, os conteúdos não pesam nos suportes, e transmitem-se por “dentes azuis” ou redes com muitos Gs (G de Geração sem peso que sucede ao peso da aceleração gravítica). Neste campo pode delinear-se uma metodologia que alicerça o projeto ancorado nos estudos críticos sobre Cultura Visual (Fernando Hernández). Digamos que as práticas pedagógicas se cruzam em diversas direções, tacteando eficácias, expressões, capacidades, inovação. O contexto é cada vez mais voraz: a pele da cultura gosta de massagens (Kerkhove; McLuhan). A Matéria-Prima de que se fala nesta revista é aquela que devolve ao seu lugar um ponto crítico da pós modernidade: o do significante. Os sintagmas são sempre processos, e neles se formam as subjectividades, ou seja, as identidades: no desenrolar do ser, onde se produz verdadeiramente o sentido, bem junto do aqui-e-agora onde está a Matéria-Prima (Foucault).info:eu-repo/semantics/publishedVersio

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Repensar els estudis catalans des de la teoria queer

Catalan Studies are basically focused on national/linguistic identity, but recent debate on Catalan identity triggered by the current pro-independent process in Catalonia, may help reshape this academic field. A more diverse approach to Catalan culture should consider sexuality, which has traditionally been banished from literary analysis as a ‘private’ matter. Here, we discussed how queer theory can reframe Catalan Studies mainly by building a specific LGBT literary tradition, identifying queer episodes and characters in the canon, questioning received meanings, promoting interdisciplinary analysis of Catalan culture and exploring the role of queer subjectivity in history

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362